<VariationArchive RecordType="classified" VariationID="1807691" VariationName="GRCh37/hg19 Xp21.1(chrX:32681049-33090616)x2" VariationType="copy number gain" Accession="VCV001807691" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-31" DateCreated="2022-12-31" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1864695" VariationID="1807691">
      <GeneList>
        <Gene Symbol="DMD" FullName="dystrophin" GeneID="1756" HGNC_ID="HGNC:2928" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp21.2-21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="31119222" stop="33339388" display_start="31119222" display_stop="33339388" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="31137344" stop="33357725" display_start="31137344" display_stop="33357725" Strand="-" />
          </Location>
          <OMIM>300377</OMIM>
          <Haploinsufficiency last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-11-20" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DMD">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 Xp21.1(chrX:32681049-33090616)x2</Name>
      <VariantType>copy number gain</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="32681049" innerStop="33090616" display_start="32681049" display_stop="33090616" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 Xp21.1(chrX:32681049-33090616)x2 AND not provided" Accession="RCV002472497" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-06-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-31" MostRecentSubmission="2022-12-31">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5420226" SubmissionDate="2022-12-28" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="C9276|not provided|copy:2" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002772365" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Quest Diagnostics Nichols Institute San Juan Capistrano" OrgID="500110" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The Xp21.1 gain involves exons 2-9 of DMD (OMIM 300377; NM_004006.3) and is predicted to cause phenotypic and/or developmental abnormalities. Haploinsufficiency of DMD due to whole gene and partial deletions, partial duplications, or sequence variants is associated with a spectrum of X-linked muscle disorders known as dystrophinopathies, which include Duchenne muscular dystrophy (DMD; OMIM 310200), Becker muscular dystrophy (BMD; OMIM 300376), and dilated cardiomyopathy-3B (CMD3B; OMIM 302045). In general, mutations leading to a complete dystrophin loss-of-function cause DMD, while those that result in reduced protein levels and/or malfunction lead to BMD (Aartsma-Rus et al., Muscle Nerve. 2006 Aug;34(2):135-44. PMID 16770791). Variants of the muscle promoter and first exon of cardiac-specific dystrophin gene expression lead to CMD3B (Muntoni et al., N Engl J Med. 1993 Sep 23;329(13):921-5. PMID: 8361506; Milasin et al., Hum Mol Genet. 1996 Jan;5(1):73-9. PMID: 8789442; Bastianutto et al., Hum Mol Genet. 2001 Nov 1;10(23):2627-35. PMID: 11726549). Intragenic DMD duplications account for approximately 10% of DMD-related muscular dystrophy cases (Lim et al., J Pers Med 2020;10(4):241, PMID: 33238405; Neri et al., Front Genet 2020;11:131, PMID: 32194622). Of note, similar duplications involving exons 2-9 of DMD have been reported in the published literature in two males with DMD (White et al., Am J Hum Genet. 2002 Aug;71(2):365-74. PMID: 12111668; Cunniff et al., J Child Neurol. 2009 Apr;24(4):425-30. PMID: 19074751). Female carriers may have milder manifestation depending on their status of X-inactivation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG/ClinGen CNV Guidelines, 2019</Attribute>
          <Citation>
            <ID Source="PubMed">31690835</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Oligo array</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number gain</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="X" innerStart="32681049" innerStop="33090616" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">2</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478099</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5420226" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

